Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)

The heavy selling pressure might have exhausted for Globus Medical (GMED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.